A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO-8400, in dermatomyositis
2020
Keywords:
-
Correction
-
Source
-
Cite
-
Save
5
References
1
Citations
NaN
KQI